Farmaceutica R
Farmaceutica REMEDIA S.A. operates a chain of pharmacies in Romania. It is also involved in the wholesale distribution of medicines to pharmacies, and public and private hospitals and clinics. In addition, the company provides packaging materials; and logistics, promotion and marketing of drugs, and pharmaceutical products registration services. The company was incorporated in 1991 and is headqua… Read more
Farmaceutica R (RMAH) - Total Assets
Latest total assets as of September 2025: RON366.64 Million RON
Based on the latest financial reports, Farmaceutica R (RMAH) holds total assets worth RON366.64 Million RON as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Farmaceutica R - Total Assets Trend (2020–2024)
This chart illustrates how Farmaceutica R’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Farmaceutica R - Asset Composition Analysis
Current Asset Composition (September 2024)
Farmaceutica R's total assets of RON366.64 Million consist of 87.2% current assets and 12.8% non-current assets.
| Asset Category | Amount (RON) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RON0.00 | 12.7% |
| Accounts Receivable | RON216.95 Million | 57.7% |
| Inventory | RON57.21 Million | 15.2% |
| Property, Plant & Equipment | RON0.00 | 0.0% |
| Intangible Assets | RON2.19 Million | 0.6% |
| Goodwill | RON0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Farmaceutica R's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Farmaceutica R's current assets represent 87.2% of total assets in 2024, an increase from 83.5% in 2020.
- Cash Position: Cash and equivalents constituted 12.7% of total assets in 2024, down from 14.1% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 57.7% of total assets.
Farmaceutica R Competitors by Total Assets
Key competitors of Farmaceutica R based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
Excelsior Medical Co Ltd
TW:4104
|
Taiwan | NT$18.80 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
Farmaceutica R - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Farmaceutica R generates 1.98x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Farmaceutica R generates $ 1.85 in net profit.
Farmaceutica R - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.12 | 1.10 | 1.13 |
| Quick Ratio | 0.90 | 0.93 | 0.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RON33.36 Million | RON 27.29 Million | RON 27.12 Million |
Farmaceutica R - Advanced Valuation Insights
This section examines the relationship between Farmaceutica R's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.10 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 19.1% |
| Total Assets | RON376.03 Million |
| Market Capitalization | $3.04 Million USD |
Valuation Analysis
Below Book Valuation: The market values Farmaceutica R's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Farmaceutica R's assets grew by 19.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Farmaceutica R (2020–2024)
The table below shows the annual total assets of Farmaceutica R from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-09-30 | RON376.03 Million | +19.09% |
| 2023-09-30 | RON315.76 Million | +10.33% |
| 2022-09-30 | RON286.20 Million | +13.99% |
| 2021-09-30 | RON251.07 Million | +2.70% |
| 2020-09-30 | RON244.46 Million | -- |